Eyevensys Named to French Tech 120 Program
Press release content from Business Wire. The AP news staff was not involved in its creation. Eyevensys Named to French Tech 120 Program February 15, 2021 GMT PARIS & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb 15, 2021-- Eyevensys, a privately held, clinical-stage biotechnology company developing non-viral gene therapies for ophthalmic diseases, today announced it has been accepted into the French Tech 120 program for 2021. This government-backed program, run by La French Tech, offers support for 120 French startups considered late-stage and in a hypergrowth phase. Participating companies benefit...
Source: apnews.com